30 April 2026
Recent updates
At The Harrow Health Care Centre, we now have meningococcal B (MenB) vaccines available.
Recent cases of meningococcal infection have been reported in the south of England, initially in Kent and more recently in Dorset, primarily affecting younger individuals.
These cases are not directly linked and remain uncommon. However, they serve as a useful reminder of the importance of ensuring vaccinations are up to date, particularly in children, teenagers and young adults.
What is MenB?
Meningitis B (MenB) is a bacterial infection caused by Neisseria meningitidis group B. It can lead to meningitis (infection of the lining of the brain and spinal cord) and, in some cases, bloodstream infection.
MenB infection is rare, but it can become serious if it occurs. It is most commonly seen in babies and young children, although teenagers and young adults are also at increased risk.
How is MenB spread?
MenB is spread through close personal contact and respiratory droplets, including:
- coughing and sneezing
- kissing
- prolonged close contact
- living in shared accommodation
This is why infection is more commonly seen in teenagers and young adults, particularly those in school, university, or shared living environments.
Why consider vaccination?
The MenB vaccine helps protect against meningococcal group B infection and significantly reduces the risk of severe illness.
In the UK, the vaccine was introduced into the routine childhood programme in 2015. This means that:
- individuals born before 2015 are unlikely to have been vaccinated
- many teenagers and young adults remain unprotected
- those vaccinated outside the UK may not have received MenB protection
For these groups, vaccination can provide additional protection and peace of mind.
Other vaccines that help protect against meningitis
Meningitis can be caused by different types of bacteria, including meningococcal and pneumococcal strains (both common causes of serious infection).
Depending on age and individual circumstances, protection may also include:
- meningococcal ACWY (MenACWY)
- pneumococcal vaccines
Our clinical team can advise on whether these are appropriate as part of a broader vaccination review.
Which vaccines do you offer?
At The Harrow Health Care Centre, we offer two UK-licensed MenB vaccines:
- Bexsero – commonly used in infants and children
- Trumenba – suitable for individuals aged 10 years and above
Both vaccines are safe and effective. Our clinical team will recommend the most appropriate option based on age and medical history.
Who should consider vaccination?
Vaccination may be particularly beneficial for:
- babies and young children
- teenagers and young adults
- those preparing to start university or move into shared accommodation
- individuals who have lived abroad
- people with certain medical conditions
Vaccination schedule
Bexsero
- Babies: 8 weeks, 16 weeks, and booster at 1 year
- Children (2–10 years): 2 doses, at least 2 months apart
- Adolescents and adults: 2 doses, at least 1 month apart
Trumenba
- Ages 10 years and over:
- 2-dose schedule (standard)
- 3-dose schedule (accelerated, for earlier protection)
Your clinician will confirm the most appropriate schedule.
Is the vaccine safe?
Both vaccines have an excellent safety profile and are widely used.
Common side effects are mild and short-lived, such as:
- soreness at the injection site
- mild fever
- fatigue
Serious side effects are very rare.
Book an appointment
If you would like to discuss MenB vaccination or review your vaccination status, our clinical team will be happy to help.
We can review all relevant vaccinations during the same appointment and advise on the most appropriate options for you or your child.
Please contact reception on 020 8861 1221 to arrange an appointment.